Enhanced myeloid specificity of CD 117 compared with CD13 and CD33

Leukemia Research

Volumn 23, Issue 4, 1999, Pages 341-347

  Nomdedéu, Josep F ^a   Mateu, Roser ^d   Altès, Albert ^b   Llorente, Andreu ^c   Rio, Carme ^c   Estivill, Camino ^a   López, Olga ^a   Úbeda, Josep ^a   Rubiol, Enriqueta ^a  

^a Hosp S Creu I Sant P   (Spain)

^b Servei d'Hematol Hosp LEsperit S   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d NONE

Author keywords

Acute leukemia; CD117; Immunophenotype

Indexed keywords

CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD36 ANTIGEN; CD45 ANTIGEN; CD7 ANTIGEN; LYMPHOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGED; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CELL LINEAGE; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0032944665     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00185-4     Document Type: Article

References (34)

1. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S. et al. Gain-of-function mutations of c-kit in humar gastrointestinal stromal tumors. Science. 279:1998;577.
2. + maturation pathway in mouse thymic T-cell development: lineages and selection. Immunity. 5:1996;147-161.
3. Muroi K., Amemiya Y., Miura Y. Specificity of CD117 expression in the diagnosis of acute myeloid leukemia. Leukemia. 10:1996;1048.
4. Ocqueteau M., Orfao A., García-Sanz R., Almeida J., González M., San Miguel J.F. Expression of the CD117 antigen (c-kit) on normal and myelomatous plasma cells. Br. J. Haematol. 95:1996;489.
5. + anaplastic large cell lymphomas. Blood. 83:1994;785.
6. Smith F.O., Broudy V.C., Zsebo K.M., Lampkin B.C., Buckley C.V., Buckley J.D. et al. Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the childrens cancer group. Blood. 84:1994;847.
7. Sincock P.M., Ashman L.K. Expression of c-kit and functional drug efflux are correlated in de novo acute myeloid leukemia. Leukemia. 11:1997;1850.
8. Nagata H., Worobec A.S., Oh C.H., Chowdhury B.A., Tannenbaum S., Suzuki Y., Metcalfe D.D. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl. Acad. Sci. USA. 92:1995;10560.
9. Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the calssification of the myelodysplastic syndromes. Br. J. Haematol. 51:1982;189.
10. Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposed revised criteria for the acute myeloid leukemias: a report of the French-American-British Cooperative Group. Ann. Intern. Med. 103:1985;626.
11. Groeneveld K., te Marvelde J.G., van den Beemd M.W.M., Hooijkaas H., van Dongen J.J.M. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia. 10:1996;1383.
12. Lanza F., Latorraca A., Moretti S., Castagnari B., Ferrari L., Castoldi G. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Cytometry. 30:1997;134.
13. Lacombe F., Durrieu F., Briais A., Dumain P., Belloc F., Bascans E. et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 11:1997;1878.
14. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., van't Veer M.B. Proposals for the immunological classification of acute leukemias. Leukemia. 9:1995;1783.
15. Miller S.A., Dykesd D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids. Res. 16:1988;1215.
16. Gu Y., Alder H., Nakamura T., Schihman S.A., Prasad R., Canaani O., Saito H., Croce C.M., Canaani E. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer. Res. 54:1994;2327.
17. Saglio G., Pane F., Gottardi E., Frigeri F., Buonaiuto M.R., Guerrasio A. et al. Consistent amounts of acute leukemia-associated p190 bcr/abl transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood. 87:1996;1075.
18. Nakao M., Yokota S., Horiike S. et al. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia. 10:1996;1463.
19. Hulley SB, Cummings SR. Designing Clinical Research. An Epidemiologic Approach. Barcelona (Spain): Ediciones Doyma, 1993.
20. Bene M.C., Bernier M., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., van't Veer M.B. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. European group for the immunological classification of leukemias (EGIL). Blood. 90:1997;499a.
21. Borowitz M.J., Shuster J., Caroll A.J., Nash M., Look A.T., Camitta B. et al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A pediatric oncology group study. Blood. 89:1997;3960.
22. Jennings C.D., Foon K.A. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 90:1997;2863.
23. Wells SJ, Bray RA, Stempora LL, Farhi DC. CD117/CD34 expression in leukemic blasts. Am J Clin Pathol 106, 192.
24. Di Noto R., Lo Pardo C., Sciavone E.M., Manzo C., Vacca C., Ferrara F., Del Vecchio L. Stem cell factor receptor (c-kit, CD117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukaemia. Br. J. Haematol. 92:1996;562.
25. Valverde L.R., Matutes E., Farahat N., Hefferman A., Owusu-Ankomah K., Morilla R., Catovsky D. C-kit receptor (CD117) expression in acute leukemia. Ann. Hematol. 72:1996;11.
26. Muroi K., Nakamura M., Amemiya Y., Suda T., Miura Y. Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leuk. Lymphoma. 16:1995;297.
27. Reuss-Borst M.A., Bühring H.J., Schmidt H., Müller C.A. AML: Immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia. 8:1994;258.
28. + immature cells. Br. J. Haematol. 97:1997;656.
29. Legrand O., Perrot J.Y., Simonin G., Baudard M., Cadiou M., Blanc C. et al. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br. J. Haematol. 100:1998;147.
30. Hanson C.A., Abaza M., Sheldon S., Ross C.W., Schnitzer B., Stoolman L.M. Acute biphenotypic leukaemia: immunophenotypic andcytogenetic analysis. Br. J. Haematol. 84:1993;49.
31. Uckun F.M., Sather H.N., Gaynon P.S., Arthur D.C., Trigg M.E., Tubergen D.G. et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the children's cancer group. Blood. 90:1997;28.
32. Guglielmi C., Cordone I., Boecklin F., Masi S., Valentini T., Vegna M.L., Ferrari A., Testi A.M., Foa R. Immunophenotype of adult and childhood acute lymphoblastic leukemia:changes at first relapse and clinico-prognostic implications. Leukemia. 11:1997;1501.
33. Vormoor J., Baersch G., Baumann M., Ritter J., Jürgens H. Flow cytometric identification of candidate normal stem cell populations in CD-45 negative B-cell precursor acute lymphoblastic leukaemia. Br. J. Haematol. 100:1998;501.